Together with the previous results, we conclude that EDNRB, particularly EDNRB-442, regulates AKT1 activation in some, but not all, breast cancer cells, and that this effect may also be present in other cancer types such as kidney cancer. Here, AKT1 is linked to breast carcinoma.